Eric Litvin shares the latest NPR Business News : Hepatitis Drug Among The Most Costly For Medicaid
Hepatitis Drug Among The Most Costly For Medicaid
A Senate investigation finds that Medicaid programs in 33 states spent more than $1 billion on the hepatitis C drug Solvaldi in a single year.
No comments:
Post a Comment